Originally Posted by
skywatch
Maybe they are looking at how commonly this drug is being prescribed in other parts of the world? Maybe they are getting it from this study published in the American Journal of Therapeutics?
https://journals.lww.com/americanthe...ment_of.7.aspx
"Meta-analysis of 15 trials, assessing 2438 participants, found that ivermectin reduced the risk of death by an average of 62% (95% CI 27%–81%) compared with no ivermectin treatment [average RR (aRR) 0.38, 95% CI 0.19 to 0.73; I2
= 49%]; risk of death 2.3% versus 7.8% among hospitalized patients in this analysis, respectively (SoF Table 2 and Figure 3). "
Oh, but unfortunately, there is no money to be made from prescribing this drug, so I doubt Merck or anyone else in the western world is interested in funding any studies beyond those referenced here.
And maybe, just maybe Ivermectin HAS NOT BEEN APPROVED for COVID by WHO or the FDA. Did you read the whole article to posted or just the snippet you posted? From your article:
"There are a number of limitations with this review. Several of the studies contributing data did not provide full descriptions of methods, so assessing risk of bias was challenging. Where descriptions of study methods were sparse or unclear, we attempted to contact authors to clarify methods, but lack of information led us to downgrade findings in several instances. Overall interpretation of findings was hampered due to variability in the participants recruited, treatment regimen, and the care offered to those in control groups. We have tried to take this variation into account through subgroup and sensitivity analyses. Nevertheless, dosing and treatment regimens and the use of ivermectin with other components of “standard care” require further research."
This would explain why the FDA hasn't approved Ivermectin for use against COVID. It's why doctors aren't prescribing it and people in Mississippi have to get it from animal pharmacies.